ORIC Pharmaceuticals, Inc. Made Headway

Fri, Apr 01, 2022 at 05:30 PM
ORIC Pharmaceuticals, Inc. Made Headway

ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ) shot up at $6.6, a gain of 23.6%. The stock appeared on our News Catalysts scanner on Mon, Mar 28, 2022 at 05:30 PM in the 'INSIDER' category. From Thu, Mar 17, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days

About ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ)

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101 and ORIC-533.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.